This topic contains a solution. Click here to go to the answer

Author Question: Which of the following was not a major area addressed by the Dodd-Frank Bill (i.e., Wall Street ... (Read 83 times)

abern

  • Hero Member
  • *****
  • Posts: 533
Which of the following was not a major area addressed by the Dodd-Frank Bill (i.e., Wall Street Reform and Consumer Protection Act of 2010).
 a. Reducing systemic threats to the U.S. financial system.
  b. Solving the too big to fail problem in the U.S. financial system.
  c. Preventing spillover effects in the financial industry.
  d. Ensuring that investment banks and others reduced the amount of skin in the game they in the mortgage industry.

Question 2

Which of the following will not cause the aggregate supply curve to fall?
 a. A decrease in the nation's average price level (i.e., the implicit price index).
  b. An increase in input prices.
  c. A decrease in the value of the domestic currency.
  d. Natural disasters.
  e. None of these answers is correct.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

leahm14

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

.D

Answer to Question 2

.A




abern

  • Member
  • Posts: 533
Reply 2 on: Jun 30, 2018
Gracias!


peter

  • Member
  • Posts: 330
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The most common treatment options for addiction include psychotherapy, support groups, and individual counseling.

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library